Dusa sells Levulan
, which competes directly with Biofrontera's Ameluz in the United States, Flaten tells investors in a research note.
District Court for the District of Massachusetts alleging trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents, covering DUSA's product LEVULAN
KERASTICK (aminolevulinic acid HCl) for topical solution, 20 percent used with DUSA's BLU-U Blue Light Photodynamic Therapy Illuminator.
In her practice, when she treats patients with conventional PDT, using ALA (with the Levulan
Kerastick) most often combined with blue-light therapy, she said she cautions patients to avoid exposure to light for up to 24 hours post procedure.
(8,9) A large number of compounds are used as photosensitizer in PDT but only photofrin (porfimer sodium), levulan
(5-ALA) and metvix (methyl aminolevulinate) have received approval from the U.S.
Sun Pharma will acquire DUSA which is a dermatology company focused on developing and marketing its Levulan
photodynamic therapy platform.
Wilmington, Massachusetts-based DUSA develops and markets Levulan
photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada and Korea.
The only Food and Drug Admmistration-approved dermatologic indication for the two topical PDT photosensitizing agents--aminolevulinic acid (Levulan
) and methyl aminolevulinate (Metvixia)--is treatment of actinic keratoses.
The guidelines note that there are no good data on treatment of nodular BCCs using the photosensitizer known as 5-aminolevulinic acid and marketed in the United States and Canada as Levulan
, which has weaker tissue penetration than does Metvix.
He offered the pearl that combining aminolevulinic acid (Levulan
) and light therapy may produce results after five treatments.
The FDA granted orphan drug status to the company's Levulan
Dusa, based in Wilmington, Del., is the developer of Levulan
photodynamic therapy (PDT) for the treatment of acne, actinic keratoses, and other dermatological conditions.
is a biopharmaceutical company engaged primarily in the development and marketing of Levulan
Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with a primary focus on dermatology.